Curcumin enhances T lymphocyte activity to inhibit colon cancer (HCT 116 and SW620) and head and neck carcinomas (SNU1041 and SCC-15) cell growth by down-regulating PD-L1 protein expression [296, 297]. The gene discussed is CD274; the disease is malignant colon neoplasm.